OS
Embla Medical hf.
OSSUY · OTC
$4.15 +0.00% (+$0.00)
Market Cap $1.77B
P/E Ratio 18.87x
Div. Yield -
ROE 10.47%
Bulios Fair Price
$4.04
2.7% downside
Current Price
$4.15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, OSSUY is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
79 /100
Cheap PEG 0.94x
P/E 18.87x
P/B 1.92x
Growth
86 /100
Growing FCF growth 37.42%
EPS growth 25.99%
Book val. growth 11.90%
Profitability
73 /100
Strong Op. margin 13.66%
Gross margin 60.28%
FCF margin 12.74%
Quality
44 /100
Average ROA 5.45%
ROIC 6.79%
Asset turnover 0.57x
Debt
65 /100
Moderate Int. coverage 6.62x
Debt/Equity 0.58x
Net debt/EBITDA 2.14x
Stability
91 /100
Stable EPS volatility 12.92%
Beta 0.46x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OSSUY
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Sveinn Sölvason
Employees
4,192
Headquarters
Reykjavík